Arrhythmias & electrophysiology

Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants

JAMA CardiolPublished Retrospective cohort study

Authors' conclusion

Results suggest that the risk of SCD/MVA in phenotype-positive carriers of FLNCtv was high.

Study context

Population
Carriers of pathogenic or likely pathogenic filamin C truncating variants (FLNCtv)112 (36%) probands
Participants
308 carriers
Outcome
Composite of:
  • SCD
  • Major ventricular arrhythmias (aborted SCD, sustained VT, appropriate implantable cardioverter-defibrillator (ICD) interventions)
Methodological detailsinternational, multicentre, 19 referral centres
  • International
  • Multicentre
  • 19 referral centres

Main finding

As reported in the abstract

SCD/MVA · median follow-up 34 (8-63) months

Individuals with sudden cardiac death (SCD)/MVA

57

19%

Annual incidence rate (per 100 person-years)

4

95% CI 3–6

Observational data: associations, not effects.

Further findings

5-variable predictive model (older age, male sex, previous syncope, NSVT, left ventricular ejection fraction (LVEF))

Time-dependent AUC at 12 months
0.76 (95% CI, 0.67-0.86)
Time-dependent AUC at 72 months
0.78 (95% CI, 0.70-0.86)
LVEF association non-linear: significant lower risk for LVEF >58%, no increase for LVEF <58%
Internal validation with bootstrapping confirmed good accuracy and calibration
Consistent in subgroups (phenotype-positive carriers; phenotype-positive carriers without MVA at onset)

Original publication

Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants. JAMA Cardiol. Published 1 April 2025. doi:10.1001/jamacardio.2024.5543

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.